WAYNE, Pa.--(BUSINESS WIRE)--Encorium Group, Inc. (Nasdaq: ENCO), a leader in the design, development, and management of complex clinical trials and patient registries for many of the world’s leading pharmaceutical and biotechnology companies, announced today that it will issue its financial results for the third quarter ended September 30, 2006 on Tuesday, November 14, 2006 after market close, with an accompanying conference call on Wednesday, November 15, 2006 at 11:00 A.M. ET.
